STIM2 and breast carcinoma: Agonist-evoked Ca2+ signals through the activation of Orai1 also fine tune breast cancer cell functions as described in triple negative breast cancer cells where progesterone attenuates cell proliferation by a mechanism involving Ca2+ entry mediated by STIM2, Orai1, and TRPC1 [39].